Immunitybio, Inc. · NASDAQ:IBRX
California Capital Equity, LLC converted 4,606,596 Immunitybio, Inc. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, California Capital Equity, LLC (10% owner) converted 4,606,596 Immunitybio, Inc. shares at US$5.43 for US$25M, leaving 251,018,873 shares. Filed Apr 2, 2026 (Form 4).
- Converted
- 4,606,596 shares
- Price
- US$5.43
- Value
- US$25M
- Holding after
- 251,018,873 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Conversion | 4,606,596 | US$5.43 | 251,018,873 | Indirect |